Table 2.
Clinical features of the novel coronavirus (COVID‐19)
| Study | Patients number | Mean age | Fever | Cough | Fatigue myalgia | Headache | Gastrointestinal symptoms | Others | References |
|---|---|---|---|---|---|---|---|---|---|
| Chang et al. | 13 | 34 | 92.3% | 46.3% | – | 23.1% | – | Upper airway congestion (61.5%) | (Chang 2020 #9) |
| Chung et al. | 21 | 51 | 67% | 43% | 14% | 14% | Nausea (5%) | – | (Chung, 2020 #10) |
| Chen et al. | 29 | 56 | 96.5% | 72.4% | 41.4% | 6.9% | Diarrhea (13.8%) | Sputum production (72.4%) Dyspnea (58.6%) | L. Chen et al. (2020) |
| Zhang et al. | 9 | 36 | 88.8% | 55.5% | 44.4% | – | – | Sore throat (44.4%) Nasal congestion (11.1%) | M. Zhang et al. (2020) |
| Kui et al. | 137 | 57 | 81.8% | 48.2% | 32.1% | 9.5% | Diarrhea (8%) | Palpitation (Less common) Hemoptysis (5.1%) Dyspnea (19%) Sputum production (4.4%) | Kui et al. (2020) |
| Chen et al | 99 | 55.5 | 83% | 82% | 11% | 8% | Diarrhea (2%) Nausea/vomiting (1%) | Dyspnea (31.3%) Confusion (9%) Sore throat (5%) Rinorrhea (4%) Chest pain (2%) | Chu et al. (2020) |
| Gaun et al. | 1,324 | 47 | 87.9% | 67.7% | – | – | – | Sever pneumonia (15.7%) | Guan et al. (2020) |
| Liu et al | 24 | 43 | 79.17% | 25% | 25% | 16.7% | Anorexia (less common) | Dizziness (16.67%) Dyspnea (8.3%) | (Liu, 2020 #1) |
| Feng et al. | 15 | – | 33.3% | 6.7% | – | – | – | – | (Feng, 2020 #14) |
| Pan et al. | 21 | 40.9 | 85.7% | 57.1% | 52.4% | – | – | Sore throat (19%) Sputim production (28.6%) | (Pan, 2020 #15) |